Viewing Study NCT01280695


Ignite Creation Date: 2025-12-24 @ 2:15 PM
Ignite Modification Date: 2026-01-27 @ 6:36 AM
Study NCT ID: NCT01280695
Status: COMPLETED
Last Update Posted: 2014-04-14
First Post: 2011-01-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients
Sponsor: Metabolic Solutions Development Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 View
None Diabetes Mellitus View
None Diabetes View
None High blood sugar View
None Blood sugar View
None Blood glucose View
None Glucose View